Transdiagnostic Cognitive Biomarkers
Sponsor: University of Minnesota • ClinicalTrials.gov ID: NCT04864080
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.
Interventions
-
Computer game/task
(Behavioral)
N-back, COGED, PacMan game, Bandit task, Websurf task.
-
Health surveys online
(Behavioral)
Health surveys to study themes like pain, sleep, depression and anxiety, and PTSD.
Eligibility criteria
Conditions
Locations
- University of Minnesota — Minneapolis, Minnesota, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record